Tivozanib Non-Oncology Buy-Back Gives Quick Cash To AVEO

 
• By Ian Haydock
Kidney cancer
AVEO To Focus On Tivozanib In Renal And Other Cancers • Source: Shutterstock

More from Strategy

More from Business